World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
114
Citations
63268
World Ranking
817
National Ranking
513

Medicine

D-Index
114
Citations
63334
World Ranking
4641
National Ranking
2521

Overview

Richard Jove is affiliated with Nova Southeastern University in the United States. Their research spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on several subfields including Molecular Biology, Oncology, Genetics, Reproductive Medicine, and Pathology and Forensic Medicine.

The scientist's research topics cover areas such as Cancer Cells and Metastasis, Mesenchymal Stem Cell Research, Pluripotent Stem Cells Research, Ovarian Cancer Diagnosis and Treatment, Cancer Mechanisms and Therapy, and PI3K/AKT/mTOR Signaling in Cancer.

Recent publications by Richard Jove include:

  • Differences and similarities between cancer and somatic stem cells: therapeutic implications, 2020, Stem Cell Research & Therapy
  • Synergistic Anti-Tumor Activity by Targeting Multiple Signaling Pathways in Ovarian Cancer, 2020, Cancers

Their work has been published in venues such as:

  • Stem Cell Research & Therapy
  • Cancers

Frequent coauthors in their research include:

  • Fiorella Rossi
  • Hunter Noren
  • Vladimir Beljanski
  • Karl-Henrik Grinnemo
  • Wei Wen

Best Publications

  • STATs in cancer inflammation and immunity: a leading role for STAT3

    Hua Yu;Drew Pardoll;Richard Jove

  • The STATs of cancer — new molecular targets come of age

    Hua Yu;Richard Jove

  • Revisiting STAT3 signalling in cancer: new and unexpected biological functions

    Hua Yu;Heehyoung Lee;Andreas Herrmann;Ralf Buettner

  • Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

    Robyn Catlett-Falcone;Terry H Landowski;Marc M Oshiro;James Turkson

  • Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

    Guilian Niu;Kenneth L Wright;Mei Huang;Lanxi Song

  • Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.

    Tianhong Wang;Guilian Niu;Marcin Kortylewski;Lyudmila Burdelya

  • Activated STAT Signaling in Human Tumors Provides Novel Molecular Targets for Therapeutic Intervention

    Ralf Buettner;Linda B Mora;Richard Jove

  • Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein

    Chao Lan Yu;Debra J. Meyer;George S. Campbell;Andrew C. Larner

  • Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.

    Marcin Kortylewski;Maciej Kujawski;Tianhong Wang;Sheng Wei

  • Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation

    James Turkson;Tammy Bowman;Roy Garcia;Eric Caldenhoven

  • Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.

    Roy Garcia;Tammy L Bowman;Guilian Niu;Hua Yu

  • Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression

    P. K. Epling-Burnette;Jin Hong Liu;Robyn Catlett-Falcone;James Turkson

  • Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

    Khandaker Siddiquee;Shumin Zhang;Wayne C. Guida;Michelle A. Blaskovich

  • Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

    Michelle A. Blaskovich;Jiazhi Sun;Alan Cantor;James Turkson

  • Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in Tumors

    Heehyoung Lee;Andreas Herrmann;Jie Hui Deng;Maciej Kujawski

  • Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways

    Qing Xu;Jon Briggs;Sungman Park;Guilian Niu

  • Constitutive Activation of Stat3 in Human Prostate Tumors and Cell Lines Direct Inhibition of Stat3 Signaling Induces Apoptosis of Prostate Cancer Cells

    Linda B Mora;Ralf Buettner;John Seigne;Jose Diaz

  • Persistent Activation of Stat3 Signaling Induces Survivin Gene Expression and Confers Resistance to Apoptosis in Human Breast Cancer Cells

    Tanya Gritsko;Ann Williams;James Turkson;Satoshi Kaneko

  • Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis

    Tammy Bowman;Martin A. Broome;Dominic Sinibaldi;Walker Wharton

  • JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance.

    Tianyi Wang;Tianyi Wang;Johannes Francois Fahrmann;Heehyoung Lee;Yi Jia Li

Frequent Co-Authors

Hua Yu
Hua Yu City Of Hope National Medical Center
William S. Dalton
William S. Dalton University of South Florida
Said M. Sebti
Said M. Sebti Virginia Commonwealth University
Eric B. Haura
Eric B. Haura University of South Florida
Andrew D. Hamilton
Andrew D. Hamilton New York University
Jie Wu
Jie Wu Temple University
Thomas P. Loughran
Thomas P. Loughran University of Virginia
Shumin M. Zhang
Shumin M. Zhang Brigham and Women's Hospital
Jin Q. Cheng
Jin Q. Cheng University of South Florida
Kapil N. Bhalla
Kapil N. Bhalla The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Richard Jove

Trending Scientists